The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks bounce back after recent sell-off

Tue, 28th May 2013 11:20

UK markets were registering impressive gains on Tuesday morning with hopes of continued monetary easing in the Eurozone lifting sentiment as stocks bounced back following last week's sharp sell-off.After reaching a 13-year high on Wednesday, the FTSE 100 dropped sharply in the latter part of last week - losing nearly 3.0% in just two days - on fears of a scaling back of stimulus measures from the US Federal Reserve as well as some gloomy economic data from China.However with UK and US markets closed for national holidays on Monday, traders were looking to play catch up after missing out on the previous day's rally. Helping the bullish mood today were comments from European Central Bank (ECB) board member Peter Praet who said that the bank could still cut interest rates if needed to support the economy. In recent interviews, Praet said that "even after cutting the cost of money to a record low of 0.50%, the ECB signalled that the possibility of further easing was not exhausted".Market Analyst Craig Erlam from Alpari said: "Investor sentiment is on the rise in Europe this morning, with stock indices following in the footsteps of their Asian counterparts over night, which recovered early losses to end the session higher." Tuesday's session was the first positive day on Tokyo's Nikkei index since it dropped by 7.3% on Thursday."Now that the dust is beginning to settle, we could be seeing traders take advantage of the dip in the market to buy on the cheap. Given that the Bank of Japan's massive bond buying programme is only just getting under way, I think this will be the case," Erlam said.The economic data calendar was on the light side on Tuesday morning in Europe, though eyes will be fixed on consumer confidence and home-price figures in the States due out this afternoon.FTSE 100: TUI Travel, pharmas and banks provide a liftTour operator TUI Travel was among the best performers this morning, rising in sympathy with French peer Club Mediterranee after its shareholders Fosun International and Axa Private Equity joined forces to make a €540m bid for the firm.Drugs giant AstraZeneca higher after saying that it will continue to "vigorously" defend the intellectual property rights protecting its asthma medicine Pulmicort Respules. The company is appealing against a US court ruling that the patent protecting Pulmicort from rival drugs in the US is invalid. Sector peers Shire and GlaxoSmithKline were also in demand early on, with the latter being boosted by an upgrade by Deutsche Bank to 'buy'.Financial stocks were also performing well as markets on the whole rebounded from last week's sell-off. HSBC, Barclays and Standard Chartered were in positive territory, joined by part-nationalised lenders RBS and Lloyds which were both shrugging off downgrades by Citigroup today.Wood Group was also higher on news that its PSN business will continue to provide duty holder and asset management services to the Hummingbird Spirit floating storage offloading production vessel, under a new contract extension worth $87m from Teekay. Positive comments from Bank of America Merrill Lynch were helping share prices of a number of retailers this morning after the broker raised its target prices for Sainsbury, Marks & Spencer and Tesco.FTSE 250: Victrex jumps after first-half reportPolymer manufacturer Victrex was a high riser on the second-tier index after increasing its interim dividend by 15% despite a slight fall in profits. The company however still managed to beat profit before tax forecasts by 2.0% in the first half.Soft drinks maker AG Barr was also up as it managed to increase revenues by 2.4% in the first quarter in spite of the dismal weather.Mining firm Kazakhmys was heading the other way after announcing that it has sold its long-held German copper products unit MKM for €42m. "MKM is an excellent business, but did not fit with our geographic and strategic focus as a natural resources company in Central Asia," the company said.FTSE 100 - RisersPetrofac Ltd. (PFC) 1,391.00p +3.81%Barclays (BARC) 328.95p +3.77%TUI Travel (TT.) 371.50p +3.63%CRH (CRH) 1,438.00p +3.45%Weir Group (WEIR) 2,373.00p +3.40%Melrose Industries (MRO) 263.70p +3.33%GKN (GKN) 305.90p +3.21%International Consolidated Airlines Group SA (CDI) (IAG) 281.60p +3.15%Babcock International Group (BAB) 1,202.00p +3.09%AstraZeneca (AZN) 3,534.00p +3.09%FTSE 100 - FallersEurasian Natural Resources Corp. (ENRC) 249.00p -2.28%Randgold Resources Ltd. (RRS) 4,921.00p -1.34%Severn Trent (SVT) 2,049.00p -1.06%Anglo American (AAL) 1,549.00p -0.48%United Utilities Group (UU.) 784.00p -0.38%Carnival (CCL) 2,229.00p -0.36%Glencore Xstrata (GLEN) 331.75p -0.03%Rio Tinto (RIO) 2,866.50p -0.02%FTSE 250 - RisersNew World Resources A Shares (NWR) 115.20p +8.88%Victrex (VCT) 1,720.00p +5.65%Pace (PIC) 260.00p +4.00%Ferrexpo (FXPO) 177.20p +3.99%Telecity Group (TCY) 979.50p +3.93%Laird (LRD) 212.10p +3.87%Inchcape (INCH) 569.50p +3.73%Ashtead Group (AHT) 655.00p +3.39%Spirax-Sarco Engineering (SPX) 2,881.00p +3.37%Homeserve (HSV) 263.60p +3.37%FTSE 250 - FallersHochschild Mining (HOC) 241.30p -2.43%Kazakhmys (KAZ) 318.40p -2.36%AZ Electronic Materials SA (DI) (AZEM) 316.30p -2.23%Kenmare Resources (KMR) 31.00p -2.08%Dunelm Group (DNLM) 854.00p -1.84%EnQuest (ENQ) 131.50p -1.28%Telecom Plus (TEP) 1,271.00p -1.24%Salamander Energy (SMDR) 164.80p -1.20%HICL Infrastructure Company Ltd (HICL) 128.60p -1.08%Carpetright (CPR) 635.00p -1.01%
More News
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.